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Abstract
Chronic wounds are a major health concern and they affect the lives of more than
25 million people in the United States. They are susceptible to infection and are the
leading cause of nontraumatic limb amputations worldwide. The wound environment is dynamic, but their healing rate can be enhanced by administration of therapies at the right time. This approach requires real-time monitoring of the wound
environment with on-demand drug delivery in a closed-loop manner. In this paper,
a smart and automated flexible wound dressing with temperature and pH sensors
integrated onto flexible bandages that monitor wound status in real-time to address
this unmet medical need is presented. Moreover, a stimuli-responsive drug releasing system comprising of a hydrogel loaded with thermo-responsive drug carriers
and an electronically controlled flexible heater is also integrated into the wound
dressing to release the drugs on-demand. The dressing is equipped with a microcontroller to process the data measured by the sensors and to program the drug release protocol for individualized treatment. This flexible smart wound dressing has
the potential to significantly impact the treatment of chronic wounds.
Keywords: automated systems, flexible electronics, on-demand drug delivery systems, pH sensors, smart bandages, wound healing

1. Introduction
Dermal injuries can render the human body significantly vulnerable to infections.1 Skin possesses excellent regeneration properties that allow its rapid
healing upon its injury.2 However, some traumatic injuries that cause significant skin damage such as burns or underlying conditions such as diabetes
can overwhelm the regenerative capacity of skin.3 In such wounds, the normal healing steps of inflammation, proliferation, and maturation do not occur as expected. For example, in diabetic patients endothelial cells do not
respond properly to the released cytokines and cannot support rapid angiogenesis.4 The low oxygen content reduces the ability of immune cells to
fight environmental pathogens and thus these wound ulcers become quickly
nonhealing.5 Studies show that over 90% of wound ulcers that were slow to
heal or recurred after clinical discharge were infected with bacteria such as
Staphylococcus aureus.6 The lack of proper immune response can lead to bacteremia and sepsis if the local infection is not treated effectively.7 As a result,
chronic wounds are one of the key causes of limb amputations.
The effective protection of the body against bacterial infection requires
a combinatorial method that can: (i) rapidly cover the wound and form a
barrier against environmental pathogens and (ii) prevent systemic infection by its early stage detection followed by localized or systemic treatment with antibiotics. Existing dressings cover the wound bed and in some
cases release therapeutic molecules passively. However, these wound dressings provide limited information about the status of the healing process
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and operate in an open loop manner. Infection is a key challenge associated with chronic wounds, and patients should either be hospitalized or be
continuously screened by medical professionals for signs of infection adding to treatment cost.7,8 Smart systems that can monitor the wound environment without the need for dressing replacement and visits to medical
facilities are extremely beneficial.9 The emergence of flexible electronics has
advanced the state-of-the-art of wearable smart biomedical devices for disease diagnosis and treatment.10 Different sensors and actuators can be integrated into a single platform capable of maintaining conformal contact
with skin.10b–d,11 Despite these advancements, wound dressings are still primitive and cannot provide information about the wound status. The use of
flexible sensors for measuring various parameters provides invaluable information helping with the selection of treatment strategy.12 For example,
one could monitor the pH of the wound environment, which is a strong indicator of bacterial infections.13 The pH of normal healing wounds is in the
range of 5.5–6.5 during the healing phase. However, in nonhealing infected
wounds, pH will be above 6.5.13a,14 Although blood pH can also be slightly
affected by diet and diseases, the variations of wound pH in response to infection are more severe. Thus, monitoring pH could provide important data
on possible infection.
Moreover, advanced medical patches can deliver therapeutics in response to the wound status in a more controlled fashion than what is possible today. Current infection therapies often require oral (systemic) and topical (e.g., on the entire wound) antibiotic administration, which need much
larger dosage than would be required if administered locally (e.g., only in
wound regions which need it). Such routes of antibiotic administration can
also have several side effects on healthy tissues or organs. A local delivery
patch, however, would overcome these drawbacks to provide more precise
and controlled administration of therapeutics within the wound region to
promote optimal wound healing. pH-responsive materials which function
through a change in their ionization and thus the polymer state have been
used for engineering self-responding drug delivery tools that can automatically release their payload.15 However, the release rate of the encapsulated
antibiotics usually depends on the environment pH and might not be sufficient to remove the pathogens and create resistance. Their critical pH is
also not easy-to-adjust, which limit their application for treatment of different wounds. Thus, systems that benefit from a separate stimulus for drug
release might be easier to use.
As a demonstration of the potential for integrated wound monitoring
and treatment using emerging flexible bioelectronics, we have engineered
a platform capable of in situ detection of bacterial infection by continuously
monitoring wound pH, as well as administration of antibiotics locally and
on demand. The electronics feature an on-board wireless transceiver that
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Figure 1. Schematic and conceptual view of the automated smart bandage. The bandage was
comprised of an array of flexible pH sensors and a flexible heater to trigger thermo-responsive drug carriers containing antibiotics. Thermo-responsive drug carriers were embedded in
a layer of alginate hydrogel which was cast around the pH sensors and on top of the flexible
heater. The sensors and heater were connected to an electronic module that could record the
sensors signal and power the heater if needed. The electronic module could also communicate wirelessly to computers and smartphones

transmits sensor data and can receive instructions for programmed drug release; such wireless communication capabilities serve not only to improve
healing but also to maintain remote engagement among physicians, caregivers, and patients throughout the wound care process.
2. Results and Discussions
A smart bandage was engineered with multiple components including: (i)
sensors (pH and temperature), (ii) microheater, (iii) thermo-responsive drug
carriers embedded in a hydrogel patch, and (iv) wireless electronics to read
the data from the sensors and to trigger and control the thermal actuation
system if required (Figure 1). pH is among the key parameters for monitoring of chronic wounds. pH of a chronic wound changes from acidic to alkaline, which is typically interpreted as an indication of the bacterial infection.16
Thus, it could be used for prescreening of chronic wounds. Additionally, the
temperature sensor was utilized to provide further information about the
wound inflammation. Thermo-responsive drug carriers were employed for
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on-demand release in response to temperature variation. For this reason,
PNIPAM-based particles were fabricated and embedded within an alginate
hydrogel sheet. The patch was directly cast on top of a flexible heater, which
in turn was controlled using the integrated microcontroller. The entire construct was attached to a transparent medical tape to form a wearable platform that was less than 3 mm thick. The platform was engineered in a way
that the sensing modules and the integrated heater were low-cost and could
be disposed, while the electronics could be reused.
Potentiometric pH sensors were designed and fabricated as described in
the Experimental Section.17 Carbon/polyaniline (PANI) and silver/silver chloride served as working and reference electrodes, respectively, and PANI was
employed as a positive exchange membrane (Figure 2 A–C). The principle
of operation involves protonation and deprotonation of working electrode
in an acid and basic environment, where charge accumulation resulted in a
voltage output that could be measured for determination of pH.
The sensor function was evaluated in terms of stability and repeatability over a wide range of pH values (from 4 to 10 and back to 4). The sensors
were sequentially placed in solutions containing Na+ (142 mmol) and Ca2+
(2.5 mmol) with an ionic composition similar to human exudate with different levels of pH and the generated potential between the working and reference electrodes was measured (Figure 2D). The potential measurement
of the sensor at each pH solution was recorded after reaching equilibrium
state and output stability was obtained. The sensors exhibited a relatively
linear response (r2 = 0.946) with average sensitivity of −50 mV pH−1. To evaluate stability, sensors were immersed in the highest and lowest physiological pH levels (6 and 8) and the change in the sensors potential was recorded
over time. The sensor yielded a stable signal with less than 6 mV drift over a
12 h period, providing an adequate stability for wound monitoring application in which dressings are typically changed on daily basis. Currently, there
is no standard test for in vitro assessment of the function of wearable sensors. Thus, to test the function of the sensor on skin, the condition was mimicked by creating agarose hydrogels (3% w/v) with different pH values. The
engineered hydrogels mimic the physical properties of the wounded skin.
The sensor was placed on top of them and the output signal was recorded.
A resistive microheater with resistance of 20Ω was designed and fabricated on a flexible parylene substrate, which was lightweight and FDA-approved (Figure 2F). Electrical power was transferred to the heater using electrical driver controlled by an Arduino microcontroller (LightBlue Bean, MA).
The microcontroller could also communicate with external sources wirelessly, using a low-energy Bluetooth module (LightBlue Bean, MA) assembled on the electrical board. For adjusting the temperature generated by
the heater and avoiding the temperature overshoot, a commercially available flexible temperature sensor (OMEGA, CT) with a linear response and
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Figure 2. Sensors fabrication and characterization. A–C) Optical images and design of the fabricated pH sensor on PET film, carbon/PANI, and silver/silver chloride served as working electrode and reference electrode.
D) Calibration plot of the pH sensor in range 4–10 with r2 = 0.95 and sensitivity of −50 mV pH−1. E) Transient
response of the pH sensor over 24 h showing its long-term stability. F) Optical image of the flexible heater
fabricated using gold electrodes on Parylene substrate. G) Calibration plot of the heater with a slope of 8 °C
V−1. H) Transient response of the heater in a wet condition shows the response time of 5 min with applied 3 V.
I) The temperature variation in response to cyclic application of voltage to the heater to change the platform
temperature. J,K) Simulation for heat distribution inside the gel before and after applied electrical power, with
consideration of the human skin showing that the generated heat influenced the hydrogel and did not impact
on skin temperature.
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sensitivity of 10 Ω °C−1 was assembled into the bandage next to the flexible
heater. The feedback from the temperature sensor was used for adjusting
the platform temperature.
The calibration graph showed that the temperature varied linearly with
respect to applied electrical power (Figure 2G). Additionally, transient graph
confirmed a relatively fast response of the microheater with a time response
of less than 5 min (Figure 2H). To evaluate the feedback control of the platform for stabilizing the temperature, microheater in combination with the
temperature sensor and electronic system was utilized. We showed the capability of the platform for dynamically switching between various temperatures. The platform was programmed to switch the temperature between 30
and 40 °C (Figure 2I). Distribution of the heat over the hydrogel onto skin was
predicted through numerical simulation using COMSOL Multiphysics. Simulation results before and after applied electrical power confirmed precise
control on temperature distribution within the hydrogel layer (Figure 2 J,K).
To be able to release antibiotics on demand, we employed stimuli-responsive drug carriers that could be triggered by applying an external stimulation. Temperature triggering mechanism was employed for delivery of
antibiotics as it was safe (at temperatures lower than 42 °C) and easy-to-apply.18 PNIPAM is a biocompatible thermo-responsive material, which can go
through hydrophilic–hydrophobic transition above its critical temperature.19
PNIPAM’s critical temperature is around 32 °C, which might make the drug
carriers susceptible to be self-triggered. However, PNIPAM can be grafted
with other monomers or copolymerized to increase its critical temperature
to ≈37 °C, reducing the possibility of undesired drug release.20
PNIPAM particles were fabricated using microfluidic flow focusing approach in which the PNIPAM solution was introduced into the microchannel
and was wrapped with an oil solution containing surfactant to form droplets.
The size of the generated droplets could be tuned by adjusting the ratio between the flow rates of the two streams. The droplets were then crosslinked
by UV irradiation. Particles with the diameter of 300 μm were fabricated,
which were shrinking as being heated above 32 °C as shown in Figure 3A.
This critical temperature of the PNIPAM particles makes them suitable for
topical applications where the skin temperature is less than 37 °C.
Details of the microparticle fabrication and drug release study can be
found in the Experimental Section. These drug carriers were embedded into
an alginate hydrogel layer (Figure 3D). A thin layer of rectangular alginate
patch (2% w/v) was formed by adding solution of sodium alginate counting
drug carriers into PDMS molds followed by spraying calcium chloride as a
crosslinker as described elsewhere.19
To minimize the thermal contact resistance between the microheater
and the hydrogel layer, the hydrogel was directly cast on top of the heater.
Chronic wounds are known for their high rate of exudate generation and
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Figure 3. Drug release study. A–C) Optical image of the particles in a range of temperatures. D–F) Fluorescence images of drug carriers embedded inside the hydrogel attached to microheater, rhodamine B was used
for better visualization. G) Release profile of cefazolin antibiotics in different temperatures and conditions. H)
Release rate control of cefazolin by adjusting the temperature.

thus exudate management is important in the proper function of the sensors and drug delivery modules. The utilized alginate-based hydrogels are
known for high water uptake and swelling ratios and have been used in
engineering wet wound dressings. In addition, since the sensors are in direct contact with the skin, the swelling of the hydrogels is not expected to
affect the readout. To visualize the drug release, rhodamine B was loaded
into PNIPAM particles and the system was heated while being monitored
under a microscope. The rhodamine B release was observed using florescent images (see Figure 3E,F). In order to load drugs, lyophilized PNIPAM
particles were soaked in cefazolin solution (10 mg mL−1) at 4 °C. Cefazolin
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is an effective antibiotics used against S. aureus, which is the most common bacteria in infected chronic wounds.6 After applying heat to the alginate patch, the cefazolin release profile was measured over time. Data
suggested a quick burst release, which was followed by a controlled release of the drug; about 80% of the drug was released over 1 h. The release
from drug carriers embedded within hydrogel was prolonged in comparison with those freely dispersed in phosphate buffered saline (PBS) (Figure
3G). As expected, higher temperatures led to faster release rate. To assess
the possibility of releasing drugs in a dynamic fashion, heat was applied
periodically (30 min on, 30 min off) and the drug release amount was determined. The results suggested that after reducing the temperature, the
antibiotic release rate was significantly reduced. By reapplying heat, the
drug release was restored (see Figure 3H).
A standard scratch test assay was used to evaluate the cell migration in
presence of bacteria. It mimics the cell migration during healing of the infected wound and shows the efficacy of the healing. To perform this experiment, the scratch was created over a monolayer of the confluent keratinocytes, which were contaminated with S. aureus in advance. Three groups
were used for this set of experiments: (1) cefazolin powder as a positive
control, (2) alginate without antibiotic loading as a negative control, and
(3) alginate containing cefazolin. The negative control showed the interaction of bacterial contamination with cell proliferation and migration observed through scratch closure. The positive control enabled us to compare
the effect of antibiotics released from the patch with free antibiotics which
indicated that the effectiveness of the antibiotics was not affected by thermal stimulation.
The dissolved cefazolin solution was used as a control to compare its effectiveness with the stimuli-responsive release patch made of alginate containing thermo-responsive drug carriers. Initial captured pictures showed a
similar distance gap for different samples (Figure 4). When alginate/Ab or
control samples were employed, rapid migration toward the opening area
was observed. Moreover, the whole distance gap was covered with migrated
cells eventually for these samples. On the other hand, the efficient migration
was not seen when alginate patch without antibiotics was used.
Wound dressing should not be cytotoxic or should not negatively affect cellular growth. Although animal studies are the most suitable tool for
preclinical assessment of the function of the wound care products, in vitro
culture of human cells is also strong tool for preliminary studies. Thus, the
engineered dressings were interfaced with the culture of human keratinocytes and potential toxicity of the engineered dressing was assessed. As it
is shown in Figure 4E,F, the cell viability and total DNA content in presence
of the antibiotic-releasing patch were similar to the control patch with viability of more than 90%.
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Figure 4. Scratch test assay test for evaluation of cell migration: A) control sample made of cefazolin solution,
B) alginate sample without antibiotic, and C) antibiotic patch. D) Quantitative analysis of the cell migration
showing the gap size on the scratch wound assay. E,F) Viability of keratinocyte and total DNA content as an indication of cellular proliferation in presence of the antibacterial and control samples.

To evaluate the efficacy of the thermo-responsive delivery of the antibiotics, zone of inhibition (ZOI) and number of colony-forming units (CFU)
tests were performed. For the ZOI test, S. aureus was cultured and added on
the surface of an agar plate. Then, two sets of the hydrogel patches with and
without antibiotics were placed on the bacterial culture. To prepare the hydrogel patch, PNIPAM particles were loaded with cefazolin and embedded
inside the alginate hydrogel. The heater was triggered to release the drug.
Significant ZOI (≈10 mm) around the patch loaded with antibiotics was observed in comparison to the control confirming the effectiveness of the released drug in inhibiting bacterial growth (Figure 5A,B).
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Figure 5. In vitro evaluation of the antibacterial activity of the bandage. A,B) Diffusion test for antibacterial
releasing hydrogel and negative control (hydrogel without antibiotics). C) Live-dead from biofilm formation
on control patch. D) Live-dead staining from biofilm formation on antibacterial patch; live bacteria appear as
green. E) CFU counting test for S. aureus using cefazolin. F) Schematics of in vitro model for culturing of S. aureus bacteria in a bioreactor monitored with pH sensor and treated with the patch loaded with antibiotic. G)
In vitro test showing the pH variation over time followed by the activation of the heater at pH = 6.5. H) The
integration of the electronic component, pH sensors, microheater, and drug-loaded hydrogel. The patch was
placed on the author’s hand.

CFU experiment was also performed to further quantify the efficacy of
the thermo-responsive antibiotic-releasing patch. While the alginate patch
without antibiotics as a negative control showed ≈100% viability ratio of the
bacteria, the use of the antibiotic-loaded patch reduced their viability ratio to less than 10% (Figure 5E). Moreover, the capability of the antibioticeluting patch on the treatment of bacterial infection was tested on a biofilm layer of the bacteria. Bacteria were cultured on the agar plates for 4 d
to create a biofilm. Then, the patch with integrated microheater was placed
on the top. Live-dead assay was used after 6 h to assess the viability of bacteria at the interface of the patch. We observed that bacteria had considerable spread over the patch and the plate in the absence of the antibiotic
(Figure 5C), while bacteria were killed significantly at the interface of the antibiotic eluting patch (Figure 5D).
In another experiment, a bioreactor was designed to evaluate the pH
variation over the bacterial culture before and after activation of the smart
patch (Figure 5F). Bacteria culture media was perfused slowly to mimic the
in vivo condition. As shown in Figure 5G, when bacteria reached the lag
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phase, the pH was reduced to 6.5 (the critical pH defined for the microcontroller in this experiment). At this pH, the bandage was automatically activated and cefazolin was released. pH raised up to 7.2 in the bioreactor with
activated bandage whereas a stable pH was seen in the nontreated sample
(deactivated bandage).
The entire platform was packaged into a flexible and wearable form that
could form conformal contact with skin. A transparent medical tape was used
for securing it onto skin. A typical fabricated bandage with the utilized electrical system is shown in Figure 5h.

3. Conclusions
In this work, we developed a networked closed-loop automated patch for
monitoring and treatment of the chronic wounds. The closed-loop patch
included sensor patch of flexible pH and temperature sensors, a hydrogel
release patch with thermoresponsive drug-loaded carriers with integrated
microheater, and an electronics patch. Flexible electrochemical pH sensor
with linear response and sensitivity of −50 mV pH−1 was designed and fabricated on flexible PET substrate. According to the feedback data from pH
sensor, thermo-responsive release patch was activated for the release of the
antibacterial drugs. Readout from the sensor and stimulation of thermo-responsive drug were achieved remotely by taking advantage of the wireless
Bluetooth low energy module in the electronics patch. The proposed bandage was characterized by in vitro bacterial study and subsequent antibiotic
release. Additionally, scratch test assay was performed to prove the cell migration over scratch. In the proposed smart bandage, pH and temperature
sensors and antibiotic drug serve as models of sensors and the drug, one
could embed more sensing components, drugs, and growth factors in this
platform for specific detection of particular healing marker and for treatment of different target conditions. The assessment of clinical advantage of
the smart and automated (feedback controlled) dressing for facilitating the
healing process of chronic wounds and its comparison to other existing technologies and wound care products requires the use of animal models that
represent difficult-to-treat wounds which will be carried out in the future.

4. Experimental Section
Materials: Chemicals including sodium alginate, agarose, CaCl2, PNIPAM, N,N′methylenebisacrylamide, and mineral oil were purchased from Sigma-Aldrich
(St. Louis, MO). Irgacure 2959 (CIBA Chemicals) was used as the photoinitiator
(PI). Cell culture reagents were obtained from Life Technologies, MA.
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Fabrication and Characterization of pH Sensor: The pH sensors were prepared
based on a previous work.17 Briefly, the pH sensor consisted of a working
electrode and a solid-state Ag/AgCl reference electrode. The voltage read
across the two electrodes corresponded to the pH level of the analyte solution. The fabrication process was conducted by laser-machining and screenprinting. The fabrication process starts by laser cutting a single layer of tape
(3M MagicTape) to act as a stencil mask for the screen-printing process. The
mask was then attached to the flexible PET substrate followed by screenprinting the carbon (MG Chemicals Graphite Conductive Coating) and silver inks (118-09, Creative Materials, Ayer, MA). After the printing process
the mask was removed, revealing four working electrodes and one reference
electrode. The inks were then cured in an oven set to 80 °C for 1 h.
Using the same laser machine and settings, the perimeter of electrodes
was removed from the PET substrate. The openings created in the PET substrate allow the interface between the drug delivering hydrogel and the
wound. Next, to prevent electrical crosstalk between the electrodes an insulating layer of poly(methyl methacrylate) (PMMA; A4) was printed onto the
conductive carbon and silver traces, which defines the active area and the
contact pad of the sensors. The insulating layer was cured by hot plate set
to 80 °C for 10 min followed by exposing to UV light for 5 min.
The Ag/AgCl reference electrode was prepared by electrodepositing a
layer of AgCl over the silver electrode. The chloridization process was performed in a solution of 1.0 m NaCl and a constant current of 1 mA for 3 min
was applied across the silver electrode and a Pt electrode. The uncovered
area of silver electrode changes in color with the formation of silver chloride. The resulting Ag/AgCl electrode was then rinsed with deionized water
and blow dried with nitrogen.
The pH-sensitive membrane was prepared by dissolving 25 mg of polyaniline emeraldine in 10 mL dimethyl sulfoxide (DMSO), both purchased
from Sigma-Aldrich, MA. For a complete dissolution, the mixture was placed
in an ultrasonic bath for 2 h followed by stirring with magnetic rod for 24
h. The solution was then remained undisturbed for 24 h to allow the undissolved particles to settle. The solution was decanted and filtered through a
500 nm filter (Whatman filters) yielding a uniform dark blue solution. The
working electrode was prepared by drop-casting 5 μL volume of the pH
polyaniline emeraldine base solution onto the active area of the carbon
electrodes and slowly dried at 50 °C for 2 h. The polyaniline film was then
doped with H+ ion by placing the device in a vacuum chamber with 2 mL
of 1 m HCl for 5 h. The HCl fumes induced by low pressure in the vacuum
chamber introduces H+ ions into the polyaniline emeraldine based membrane, which was then converted to polyaniline emeraldine salt. The electrodes were then rinsed with DI and dried with nitrogen.

Mostafalu, Tamayol, et al. in Small 2018

14

The solid-state reference membrane was made by mixing 1:1 ratio of
fine KCl powdered (Sigma-Aldrich) with UV-curable adhesive (Henkel Loctite
3105). The blend was thoroughly mixed using ultrasound, forming a uniform
slurry. The slurry was then cast onto the Ag/AgCl electrode and cured under UV light for 10 min. During the UV exposure, the working electrode was
protected with an aluminum foil cover. The measurements were conducted
in different pH buffer solutions ranging from pH of 4 to pH of 10. The buffered solutions were purchased from Nova Analytics (Pinnacle pH Buffers).
The performance of the fabricated sensors was assessed by potentiometric measurements across the pH-sensitive working electrode Ag/AgCl reference electrode with using a BASI potentiostat.
Fabrication of Microheater and Temperature Sensor: Microheater was designed and prepared based on a previous work.21 For fabrication of the microheater, first a glass wafer was covered by 25 μm parylene as a substrate
using parylene coater (PDS2010) with 20 g of dimer. The wavy geometry of
the microheater was designed in CAD software to be used as a mask. Adhesive mask was prepared with a laser cutter (Versa, VLS2.40) (power 40%,
speed 20%) and attached to the substrate. A 20 nm chromium as an adhesive layer and a 200 nm gold layer were sputtered subsequently. Then, adhesive mask was peeled off and left behind a wavy pattern with 20 Ω resistance.
For the characterization of the microheater using electronic driver, constant voltage was applied using an electronic driver board.
Particle Characterization and Drug Loading: A microfluidic coflowing device
was used to fabricate PNIPAM microparticles. In this system, a 10% (w/v)
PNIPAM, 0.3% (w/v) N,N-methylene-bis-acrylamide (BIS), and 0.5% (w/v) of
PI solution in water was injected through the central nozzle using a syringe
pump. A solution of mineral oil containing 20% (v/v) of Span80 as surfactant
was injected using another syringe pump to form a sheath around the central stream. The core flow was broken into spherical droplets and the droplet size could be tuned by changing the flow rates using two syringe pumps.
Once the microdroplets have been formed, they are collected in a Petri dish
and are polymerized by UV-light for 3 min in the temperature around 4 °C
and the UV intensity of 850 mW and the distance between the tip of the fiber optic and the Petri dish is set to 6 cm. Subsequently, the microhydrogels were washed with ethanol and distilled water several times to remove
the environmental oil and then were verified under microscope visually, after
that the particles were freeze-dried and stored in 4 °C for future experiments.
The freeze-dried microcarriers were immersed in distilled water with
drug (concentration) and they swell promptly to their original size while
absorbing the drug. When temperature reached above lower critical solution temperature (LCST) phase transition occurred and the particles change
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from hydrophilic polymer to a hydrophobic polymer, this alteration led to
an ejection of water. This drying and swelling behavior was a reversible process that did not cause morphological damage.
Drug Release with Integrated Heaters: Alginate hydrogel with embedded
drug microcarriers was attached on the surface of the microheater while 200
μL PBS was added into the plate and electrical voltage was applied to generate heat. The drug released into the solution was evaluated using plate
reader.
Bacterial Study: A single colony of S. aureus was inoculated into 10 mL liquid broth (LB) culture medium overnight. For preparation of the fresh bacteria solution, 100 μL of this sample were added to a 10 mL LB and incubated
at 36 °C, 200 rpm overnight. After being incubated and reaching OD600 of
≈0.4, 1 mL of the fresh bacteria was spread on an LB agar plate, the strain
enters the exponential period of growth and the culture broth was diluted.
Bacteria with the concentration of ≈1 × 105 cells mL−1 were cultured for ZOI
and CFU counting experiments. To investigate the application of device on
bacteria, the device was placed on the surface of cultured bacteria, and different electrical voltages were applied to the conductive pattern to generate
heat. A blank control sample without antibiotics was prepared for comparison. All the plates were incubated at 37 °C for an appropriate time. Finally,
the plates were taken out of the incubator and the ZOI and number of remaining CFUs were calculated.
Scratch Wound Healing Assay and Cell Studies: Adult Normal Human Epidermal Keratinocytes purchased from ATCC were cultured in a DMEM-based
medium containing 10% FBS and 1% penicillin/ streptomycin. For cytotoxicity assessment, circular samples (1 cm in diameter) were prepared and placed
at the bottom of 24-well polystyrene plates. Then, cells were resuspended
in culture media at the concentration of 1 × 107 cells mL−1 and 5000 cells
were seeded on the samples. The samples were incubated for 1 h to allow
the cells to attach and then 300 μL of culture medium was added to each
well. Cellular metabolic activity was measured using PrestoBlue assay on
days 1, 3, and 7 as per manufacturer’s protocol. The fluorescent intensity of
the assay was measured using a BioTek UV/vis Synergy 2 microplate reader.
Keratinocytes (1 × 105) were seeded and cultured in a six-well plate and
kept overnight to make a confluent monolayer overnight. The 1 mm wide
gap scratch was then created onto the monolayer with a 200 μL pipette tip,
and floating cells were removed by twice washing with PBS. After the line
scratches, 2 mL of DMEM was added for each group. To detect the efficacy
of treatments on cell migration, samples were continually imaged for 0, 8,
24, and 48 h. Images of the monolayer were taken by a microscope and cell

Mostafalu, Tamayol, et al. in Small 2018

16

migration activity was evaluated as the migration distance from the edges
of the scratch toward the center of it using Image J software (NIH, Bethesda,
MD, USA). For each well, ten images were taken and selected randomly. Experiments were done independently in triplicate.
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